ArticleAdvances in therapy2023

Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries.

Eva Funding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.